...BRCA1 mRNA expression is a differential modulator of chemotherapy sensitivity. Single nucleotide polymorphisms in the ex...
...BRCA1/BRCA2 breast carcinoma and to determine the factors that may predict their risk of CBC.,The study sample consisted...
...BRCA1-associated cancers. Like BRCA1-deficient tumors, most BLC lack markers of a normal inactive X chromosome (Xi). Dup...
...BRCA1 and BRCA2 mutations. Ovarian cancer patients were tested for BRCA1 mutations. We estimated standardized incidence ...
...BRCA1 and 7 cases with BRCA2.,The present study showed a continuous increase in the number of patients with breast cance...
...BRCA1 and BRCA2.,Real-time polymerase chain reaction amplification with SYBR Green I detection was performed on DNA from...
...BRCA1-associated protein, BAAT1 (BRCA1-associated protein required for ATM activation-1), by yeast two-hybrid screening ...
...BRCA1/2 mutations in order to create a biorepository for use in identifying biomarkers of breast cancer risk.,Between Ma...
...BRCA1 or BRCA2 mutations are at substantial risk for breast and ovarian cancer. This review describes recent development...
...BRCA1/BRCA2 mutations. Jewish Israeli women with breast cancer (n=385) were genotyped for the three predominant Jewish m...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
